SciELO - Scientific Electronic Library Online

vol.110 número1Impacto del cambio climático en las enfermedades infecciosasBronquiectasias en pediatría, aproximación diagnóstica y tratamiento índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados



  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO


Archivos argentinos de pediatría

versión impresa ISSN 0325-0075


BES, David F; SBERNA, Norma  y  ROSANOVA, María Teresa. Advantages and drawbacks of amphotericin formulations in children: literature review. Arch. argent. pediatr. [online]. 2012, vol.110, n.1, pp. 46-51. ISSN 0325-0075.

Fungal infections have increased in morbidity, and the range of fungal species causing disease in humans has expanded, mainly due to the rise in number of immunocompromised patients. Am-photericin B is a broad spectrum antifungal agent that has been the standard therapy for many life-threatening mycoses for the past 50 years. However, the use of this drug is commonly associated with infusion related events (such as chills, fever, headache, nausea, vomiting), and most signif-cantly to dose limiting nephrotoxicity. Three lipid formulations that increase the therapeutic index have been approved for use. However, questions regarding dose, cost-effectiveness and indications exist in the pediatric setting. Although no high quality evidence studies in children comparing the four types of amphotericin in culture-positive fungal infections currently exist, all four preparations are believed to have similar effectiveness. High drug costs limit the use of lipid formulations; however, renal toxic side effects should be taken into account when costs are considered.

Palabras clave : Amphotericin; Side effects; Toxicity; Children; Pharmacoeconomics; Kidney.

        · resumen en Español     · texto en Español     · Español ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License